Try
Grifols SA
GRFSUnited States
19 filed reports · 688 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
19 reports · Dec 2017 to Feb 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 21 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Interim · 6-KSEC EDGAR | 10 | 19 | Feb 2023 to Feb 2026 |
| Annual · 20-FSEC EDGAR | 9 | 6,770 | Dec 2017 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q1 | 6-K | Feb 26, 2026 | Feb 26, 2026 | 2 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Apr 17, 2026 | 1,476 | Open |
| FY2025 Q3 | 6-K | Jul 30, 2025 | Jul 30, 2025 | 2 | Open |
| FY2025 Q1 | 6-K | Feb 27, 2025 | Feb 27, 2025 | 4 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Apr 11, 2025 | 831 | Open |
| FY2024 Q3 | 6-K | Jul 30, 2024 | Jul 30, 2024 | 1 | Open |
| FY2024 Q2 | 6-K | May 14, 2024 | May 14, 2024 | 1 | Open |
| FY2024 Q1 | 6-K | Mar 1, 2024 | Mar 1, 2024 | 2 | Open |
| FY2024 Q1 | 6-K | Feb 29, 2024 | Feb 29, 2024 | 1 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Apr 19, 2024 | 627 | Open |
| FY2023 Q4 | 6-K | Nov 2, 2023 | Nov 2, 2023 | 2 | Open |
| FY2023 Q3 | 6-K | Jul 27, 2023 | Jul 27, 2023 | 2 | Open |
Financial data
688 concepts · 6,789 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial662 concepts · 6,069 facts · Dec 2011 to Dec 2025
- Balance at end of year144 · Dec 2014 to Dec 2025
- Other financial liabilities52 · Dec 2016 to Dec 2025
- Bonds and other marketable securities40 · Dec 2016 to Dec 2025
- Other current liabilities40 · Dec 2016 to Dec 2025
- Other public entities40 · Dec 2016 to Dec 2025
- Senior secured debt38 · Dec 2016 to Dec 2025
- Amount extended36 · Dec 2016 to Dec 2025
- Cash and cash equivalents24 · Dec 2014 to Dec 2025
- Current provisions (IFRS)24 · Dec 2014 to Dec 2025
- Deferred tax liability asset24 · Dec 2014 to Dec 2025
- Equity24 · Dec 2014 to Dec 2025
- Investment accounted for using equity method24 · Dec 2014 to Dec 2025
- Noncurrent provisions (IFRS)24 · Dec 2014 to Dec 2025
- Assets (IFRS)22 · Dec 2015 to Dec 2025
- Goodwill (IFRS)22 · Dec 2015 to Dec 2025
- Intangible assets other than goodwill22 · Dec 2015 to Dec 2025
- Liabilities (IFRS)22 · Dec 2015 to Dec 2025
- Property plant and equipment22 · Dec 2015 to Dec 2025
- Total carrying amount22 · Dec 2016 to Dec 2025
- Total contractual flows22 · Dec 2016 to Dec 2025
- Advance payments (note 30)20 · Dec 2016 to Dec 2025
- Bank borrowings undiscounted cash flows20 · Dec 2016 to Dec 2025
- Cash (IFRS)20 · Dec 2016 to Dec 2025
- Cumulative accrual amount20 · Dec 2016 to Dec 2025
Segment13 concepts · 452 facts · Dec 2015 to Dec 2025
- Revenue88 · Dec 2015 to Dec 2025
- Profit loss from operating activities54 · Dec 2015 to Dec 2025
- Revenue and operating income (IFRS)49 · Dec 2015 to Dec 2024
- Other material noncash items (IFRS)48 · Dec 2015 to Dec 2025
- Additions to noncurrent assets (IFRS)47 · Dec 2015 to Dec 2024
- Depreciation and amortisation expense46 · Dec 2015 to Dec 2024
- Total Liabilities45 · Dec 2016 to Dec 2025
- Share of profit loss of associates and joint ventures accounted for using equity method20 · Dec 2015 to Dec 2023
- Operating Segments18 · Dec 2022 to Dec 2025
- Amortisation expense12 · Dec 2023 to Dec 2025
- Profit loss (IFRS)12 · Dec 2023 to Dec 2025
- Total Assets8 · Dec 2024 to Dec 2025
- Profit/(loss) of equity accounted investees with similar activity to that of the Group5 · Dec 2023 to Dec 2025
Geography9 concepts · 187 facts · Dec 2015 to Dec 2025
- Revenue71 · Dec 2015 to Dec 2025
- Additions to noncurrent assets (IFRS)44 · Dec 2015 to Dec 2025
- Total Assets40 · Dec 2016 to Dec 2025
- Applicable tax rate17 · Dec 2015 to Dec 2025
- Average effective tax rate7 · Dec 2017 to Dec 2023
- Postemployment benefit expense defined contribution plans3 · Dec 2023 to Dec 2025
- Current tax expense income related to pillar two income taxes2 · Dec 2024 to Dec 2025
- Tax effect from change in tax rate2 · Dec 2017 to Dec 2025
- Germany1 · Dec 2025
Product1 concepts · 62 facts · Dec 2016 to Dec 2025
- Revenue62 · Dec 2016 to Dec 2025
Guidance3 concepts · 19 facts · Feb 2023 to Feb 2026
- Revenue Growth Guidance9 · Feb 2023 to Jul 2024
- Free Cash Flow Guidance6 · Mar 2024 to Feb 2026
- Revenue Guidance4 · Feb 2025
Segments
701 factsFigures broken down by business line, region, product or another axis the company reports on.
Segments14 members · 452 facts
- Diagnostic86 · Dec 2015 to Dec 2025
- Bio Supplies74 · Dec 2015 to Dec 2025
- Other Segments69 · Dec 2015 to Dec 2024
- Hospital50 · Dec 2015 to Dec 2021
- Biopharma49 · Dec 2020 to Dec 2025
- Bioscience48 · Dec 2015 to Dec 2021
- All Other Segments23 · Dec 2023 to Dec 2025
- Diagnostic12 · Dec 2016 to Dec 2025
- Bio supplies9 · Dec 2018 to Dec 2025
- Other segments9 · Dec 2016 to Dec 2024
- Biopharma7 · Dec 2021 to Dec 2025
- Bioscience6 · Dec 2016 to Dec 2021
- Hospital6 · Dec 2016 to Dec 2021
- All other segments4 · Dec 2024 to Dec 2025
Geographical areas15 members · 187 facts
- Country Of Domicile32 · Dec 2015 to Dec 2025
- European Union Excluding Spain22 · Dec 2015 to Dec 2025
- Rest Of World22 · Dec 2015 to Dec 2025
- United States And Canada22 · Dec 2015 to Dec 2025
- US13 · Dec 2017 to Dec 2025
- ES12 · Dec 2015 to Dec 2025
- European union excluding spain10 · Dec 2016 to Dec 2025
- Rest of world10 · Dec 2016 to Dec 2025
- United states and canada10 · Dec 2016 to Dec 2025
- Country of domicile10 · Dec 2016 to Dec 2025
- Ifrs European Union9 · Dec 2015 to Dec 2023
- Usa And Canada9 · Dec 2015 to Dec 2023
- IE3 · Dec 2024 to Dec 2025
- DE2 · Dec 2025
- HK1 · Dec 2025
Products and services7 members · 62 facts
- Bio Supplies Product10 · Dec 2016 to Dec 2025
- Haemoderivatives10 · Dec 2016 to Dec 2025
- Other Diagnostic10 · Dec 2016 to Dec 2025
- Others Product10 · Dec 2016 to Dec 2025
- Transfusional Medicine10 · Dec 2016 to Dec 2025
- Fluid Therapy And Nutrition6 · Dec 2016 to Dec 2021
- Hospital Supplies6 · Dec 2016 to Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.